Author:
Bartlett J B,Michael A,Clarke I A,Dredge K,Nicholson S,Kristeleit H,Polychronis A,Pandha H,Muller G W,Stirling D I,Zeldis J,Dalgleish A G
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Alexander LN, Wilcox CM (1997) A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers. AIDS Res Hum Retroviruses 13: 301–304
2. Armitage JO (1998) Emerging applications of recombinant human granulocyte–macrophage colony-stimulating factor. Blood 92: 4491–4508
3. Atkins MB (1997) The treatment of metastatic melanoma with chemotherapy and biologics. Curr Opin Oncol 9: 205–213
4. Corral LG, Haslett PA, Muller GW, Chen R, Wong LM, Ocampo CJ, Patterson RT, Stirling DI, Kaplan G (1999) Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-α. J Immunol 163: 380–386
5. Davies FE, Raje N, Hideshima T, Lentzsch S, Young G, Tai YT, Lin B, Podar K, Gupta D, Chauhan D, Treon SP, Richardson PG, Schlossman RL, Morgan GJ, Muller GW, Stirling DI, Anderson KC (2001) Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. Blood 98: 210–216
Cited by
136 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献